Cost-effectiveness analysis of cochlear dose reduction by proton beam therapy for medulloblastoma in childhood

Abstract

Proton beam therapy with cochlear dose reduction improves health outcomes at a cost that is within the acceptable cost-effectiveness range from the payer's standpoint.